A multiclinic, placebo-controlled, double-blind study of prostaglandin E1 in Raynaud's syndrome.

Prostaglandin E1 (alprostadil, Prostin VR Sterile Solution, PGE1) was evaluated in patients with Raynaud's syndrome in a multiclinic, placebo-controlled, double-blind study. A total of 55 patients with either primary Raynaud's disease or Raynaud's disease secondary to systemic sclerosis were randoml...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Ann Rheum Dis
Principais autores:	Mohrland, J S, Porter, J M, Smith, E A, Belch, J, Simms, M H
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMJ Publishing Group 1985
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC1001768/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3904643/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/ard.44.11.754
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!